Skip to content

Revvity RVTY Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$453.55M-7.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3.1B-10.7%
Danaher logo
DanaherDHR
Illumina logo
IlluminaILMN
Labcorp Holdings logo
Labcorp HoldingsLH
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's accrued liabilities, current?
Revvity (RVTY) reported accrued liabilities, current of $493.13M in Q1 2026.
How has Revvity's accrued liabilities, current changed year-over-year?
Revvity's accrued liabilities, current increased by 5.0% year-over-year, from $469.86M to $493.13M.
What is the long-term trend for Revvity's accrued liabilities, current?
Over 5 years (2020 to 2025), Revvity's accrued liabilities, current has grown at a -10.0% compound annual growth rate (CAGR), from $943.92M to $556.95M.